Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 877.00
+0.70 (0.08%)
Apr 3, 2026, 1:44 PM IDT
Epitomee Medical Market Cap
Epitomee Medical has a market cap or net worth of 263.86 million as of April 2, 2026. Its market cap has decreased by -7.18% in one year.
Market Cap
263.86M
Enterprise Value
238.10M
Revenue
679.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
877.00
Market Cap Chart
Since December 15, 2021, Epitomee Medical's market cap has decreased from 1.21B to 263.86M, a decrease of -78.11%. That is a compound annual growth rate of -29.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 263.86M | 44.80% |
| Dec 31, 2025 | 182.22M | -32.71% |
| Dec 31, 2024 | 270.81M | 149.63% |
| Dec 31, 2023 | 108.48M | -67.89% |
| Dec 29, 2022 | 337.85M | -63.70% |
| Dec 30, 2021 | 930.82M | -22.80% |
| Dec 15, 2021 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 110.38B |
| Danel (Adir Yeoshua) | 2.64B |
| BrainsWay | 1.72B |
| Kamada | 1.50B |
| Ilex Medical | 684.94M |
| Novolog (Pharm-Up 1966) | 510.87M |
| Bonus BioGroup | 428.71M |
| Geffen Residence & Renewal | 268.22M |